Performance of FDG PET/CT in the Clinical Management of Breast Cancer

01.02.2013

The article assesses the strengths and limitations of 18F FDG in the management of breast cancer and addresses if 18F FDG PET/CT is useful to differentiate malignant from benign breast lesions. It also offers recommendations for clinical practice.

Related Articles